Compare · MDLN vs TRXC
MDLN vs TRXC
Side-by-side comparison of Medline Inc. (MDLN) and TransEnterix, Inc. (TRXC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and TRXC operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $44.40B.
- MDLN has hit the wire 20 times in the past 4 weeks while TRXC has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for TRXC).
- Company
- Medline Inc.
- TransEnterix, Inc.
- Price
- $33.80+0.58%
- -
- Market cap
- $44.40B
- -
- 1M return
- -19.55%
- -
- 1Y return
- -17.07%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- AMEX
- IPO
- 2025
- n/a
- News (4w)
- 20
- 0
- Recent ratings
- 25
- 0
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)
Latest TRXC
- SEC Form 8-K filed
- SEC Form 10-K filed
- Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021
- SEC Form 8-K filed
- Asensus Surgical Announces FDA Clearance in General Surgery
- Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences Conference
- SEC Form 8-K filed
- SEC Form 8-K filed
- TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided Surgery
- TransEnterix Announces New Training Center in EU